𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer

✍ Scribed by Lalle Hammarstedt; David Lindquist; Hanna Dahlstrand; Mircea Romanitan; Liselotte Onelöv (Dahlgren); Jeanna Joneberg; Nomi Creson; Johan Lindholm; Weimin Ye; Tina Dalianis; Eva Munck-Wikland


Publisher
John Wiley and Sons
Year
2006
Tongue
French
Weight
106 KB
Volume
119
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Smoking and alcohol are well‐known etiological factors in tonsillar cancer. However, as in cervical cancer, human papillomavirus (HPV) is currently found in a sizable proportion of tonsillar cancer. Recent reports from the U.S. and Finland show an increase in the incidence of tonsillar cancer, without a parallel rise in smoking and alcohol consumption. This study investigates whether the incidence of tonsillar cancer has also changed in Sweden and whether a possible explanation of the increase is a higher proportion of HPV‐positive tonsillar cancer. The incidence of tonsillar cancer between 1970 and 2002 in the Stockholm area was obtained from the Swedish Cancer Registry. In parallel, 203 pretreatment paraffin‐embedded tonsillar cancer biopsies taken during 1970–2002 from patients in the Stockholm area were tested for presence of HPV DNA by PCR. The incidence of tonsillar cancer increased 2.8‐fold (2.6 in men and 3.5 in women) from 1970 to 2002. During the same period, a significant increase in the proportion of HPV‐positive tonsillar cancer cases was observed, as it increased 2.9‐fold (p < 0.001). The distribution of HPV‐positive cases was 7/30 (23.3%) in the 1970s, 12/42 (29%) in the 1980s, 48/84 (57%) in the 1990s and 32/47 (68%) during 2000–2002. We have demonstrated a highly significant and parallel increase both in the incidence of tonsillar cancer and the proportion of HPV‐positive tumors. Hence, HPV may play an important role for the increased incidence of tonsillar cancer. This should definitely influence future preventive strategies as well as treatment for this type of cancer. © 2006 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


The role of human papillomavirus in the
✍ Per Attner; Juan Du; Anders Näsman; Lalle Hammarstedt; Torbjörn Ramqvist; Johan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 155 KB 👁 1 views

## Abstract Numerous reports have shown that the incidence for oropharyngeal cancer is increasing and that human papillomavirus (HPV) is a risk factor. However, few studies have investigated the specific subsites of the oropharynx. Following our previous research on tonsillar cancer, we assessed th

Human papillomavirus and risk factors fo
✍ Silvia Franceschi; Thangarajan Rajkumar; Salvatore Vaccarella; Vendhan Gajalaksh 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 92 KB 👁 2 views

## Abstract To evaluate the role of human papillomavirus (HPV) and other risk factors in the aetiology of invasive cervical carcinoma (ICC), we conducted a hospital‐based case‐control study in Chennai, Southern India. A total of 205 ICC cases (including 12 adenocarcinomas) and 213 frequency age‐mat

Human papillomavirus cervical infection
✍ S.A. Tonon; M.A. Picconi; J.B. Zinovich; D.J. Liotta; P.D. Bos; J.A. Galuppo; L. 📂 Article 📅 1999 🏛 Hindawi Publishing Corporation 🌐 English ⚖ 73 KB 👁 2 views

Objective: To assess the prevalence and potential risk factors associated with human papillomavirus (HPV) cervical infection among women residing in a region of northeastern Argentina with a high incidence of cervical cancer. Methods: A case-control study of 330 women participating in a cervical cy

Test positivity cutoff level of a high r
✍ Laura Kotaniemi-Talonen; Nea Malila; Pekka Nieminen; Ahti Anttila; Jussi Tarkkan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 134 KB 👁 2 views

## Abstract We present data on test positivity, relative sensitivity, rates of detection and relative specificity for primary human papillomavirus (HPV) testing with different cutoff levels for test positivity, in comparison to conventional cytology. In 2003–2004, 18,438 women were screened primari